Nextseq 2000 DNA sequencer silver support subscription plan
Ended Purchase Order Awarded Last action
- Contract number
- W911QX22P0170
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $162,272
Award facts
- Opportunity
-
- Intent to Sole Source Illumina, Inc. NextSeq 2000 Silver Support Plan Subscription Solicitation · W911QX22Q0215 · Posted Sep 23, 2022
- Contract value 76% obligated
-
- $162,271.63 Current, with exercised options
- $214,492.63 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Research Development and Engineering Command Army Materiel Command, Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Fixed Price Award Fee
- Place of performance
- Hyattsville, MD 20783, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $22,999 | |
| Change Order | $0 | |
| Exercise an Option | $48,209 | |
| Exercise an Option | $46,425 | |
| Original award | $44,639 |
About this award
The U.S. Army Research, Development and Engineering Command (RDECOM) awarded a $214,492.63 fixed-price award-fee purchase order to Illumina, Inc. on September 27, 2022, for a NextSeq 2000 DNA Sequencer Silver Support Subscription Plan. The contract, which carries no set-aside designation, will be performed at the government facility in Adelphi, Maryland, and is scheduled for completion by October 23, 2027. This award supports Illumina's genomic sequencing capabilities, which are critical to defense research applications, including genetic analysis for biodefense, pathogen identification, and related scientific investigations conducted by Army research facilities.
Illumina, a San Diego-based biotechnology company specializing in DNA and RNA sequencing platforms, is well-positioned as a prime contractor for this support subscription, having demonstrated extensive experience delivering advanced genomic technologies across federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Agriculture. The Silver Support Subscription Plan will provide maintenance and support services for the NextSeq 2000 sequencing instrument, ensuring continuity of genomic analysis operations at the Army's Adelphi research facility and supporting the broader mission of the defense research community's biotechnology initiatives.
Quick answers
Who was awarded contract W911QX22P0170?
W911QX22P0170 was awarded to Illumina, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on September 27, 2022.
How much is contract W911QX22P0170 worth?
The government has obligated $162,272 on W911QX22P0170. Its potential value, with all options, is $214,493.
Which agency awarded contract W911QX22P0170?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QX22P0170, with funding from Research Development and Engineering Command (Army Materiel Command).
Was contract W911QX22P0170 competed?
The extent of competition for W911QX22P0170 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award